Skip to content
BIOS Health logo

BIOS Health

BIOS Health is a YC Winter 2017 (W17) company. Based in Cambridge, England, United Kingdom; England, United Kingdom. Team of 45.

  • Artificial Intelligence
  • Neurotechnology

About BIOS Health

GPAgent's own fund-neutral profile, written from public information. Updated Oct 5, 2026.

Summary

BIOS Health builds neural interface hardware and AI software that reads and writes signals carried by the peripheral nervous system, giving researchers and clinicians real-time access to the body's neural data. The platform serves pharmaceutical and medical-device developers who need precise, data-driven insight into how nerves govern organ function and disease. It replaces blunt, trial-and-error approaches to neuromodulation and drug development with closed-loop, signal-level feedback from the nervous system.

Go-to-market

BIOS targets pharmaceutical companies and medical researchers through partnerships, providing its neural interface and AI platform as the underlying infrastructure for developing new neural digital therapies and drug candidates.

From the Y Combinator listing

How BIOS Health describes itself in Y Combinator's public directory. Original listing (opens in a new tab)

Neural interfaces to understand and use nerve data in medicine.

BIOS Health was previously called Cambridge Bio-Augmentation Systems (CBAS) and focused on prosthetic neural interfaces as a first market. Now we use

Facts

Industry
Healthcare / Healthcare
Location
Cambridge, England, United Kingdom; England, United Kingdom
Team size
45
Status
Active
Stage
Early

Founders (2)

Score every batch against your own thesis

GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.

How Accelerator intelligence works